Teradyne Semiconductor Testing & The Robotics Pivot

Teradyne Semiconductor Testing & The Robotics Pivot

Analyzed Watch on YouTube Requested On
Video return
Calls
1
Buy / Sell
1 0
Published

Recommendations

Entry is the asset's closing price on the publication date. Current is the last close on record.

  1. TER NASDAQ BUY +0.00%
    Entry $372.06 08 Sep 2026
    Current $372.06 08 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    …S scorecard is trends proprietary framework. It takes technicals, fundamentals demand sentiment and macroeconomic factors, strips out the narrative bias and synthesizes it all into a single actionable score. >> Okay, what's the verdict? >> Starting with the raw composite score, Pterodine comes in at a 66.2. In trend system, a 66.2 actually places it at the very bottom edge of a buy band. >> I am genuinely surprised. A buy rating for a company trading at 48 times earnings facing a cyclical downturn. How does the math justify that? >> The fundamental score is carrying almost the entire weight of that rating. Pterodine scored…

    Starting with the raw composite score, Pterodine comes in at a 66.2. In trend system, a 66.2 actually places it at the very bottom edge of a buy band.

Full Transcript
Imagine a massive company um worth about 55.8 billion dollars, >> right? That's a huge player. >> Yeah, exactly. And they have this highly touted robotics division that has basically done nothing but struggle for four straight years. >> Just bleeding cash, >> right? We're talking revenue dropping year after year, missed targets, and it gets so bad that they are actually forced to lay off 25% of the robotics workforce, >> which is brutal. >> It is. I mean on paper it looks like a completely failed diversification experiment but then almost overnight that exact same struggling division suddenly becomes a hidden sort of backdoor play on the most lucrative trend in the world right now. >> The massive AI infrastructure growth. >> Oh, exactly. >> It's honestly one of the most fascinating corporate plot twists out there right now. You know, you have a segment that was dragging down the broader narrative of the company. Yeah. >> And then the entire end market just rotates. The thing that was universally viewed as this huge liability suddenly morphs into the exact catalyst driving all their current hype >> which makes it the perfect subject for today's deep dive. We are unpacking a really detailed analysis of Pterodine >> ticker symbol TER >> right Pterodine. And we're looking at how they are attempting to bridge their legacy semiconductor testing business with this massive pivot into robotics automation. And to really get into the weeds on this, we're relying on some heavyhitting research from Trent Grinkmire. >> Yeah, his stuff is great. >> It really is. And for those of you listening, Trent Shender's background gives this analysis a ton of weight. He's the co-host of the Morning Edge and a partner at Best of US Investors, >> which is an awesome platform, >> right? But before that, he actually co-founded Grank Meyer Leonard Financial, and he ran that practice for um 22 years before selling it in 2022. >> Wow. 22 years. >> Yeah. he put his time in. Now, he dedicates himself entirely to this kind of intensive financial research and portfolio modeling, >> which is why we're so lucky to have his notes today. But, you know, given that we are leaning so heavily into Trent's proprietary portfolio models for this deep dive, we really should set some expectations for you listening. >> Yeah, we absolutely need clear boundaries whenever we dig into specific tickers and price zones. >> Definitely. So, just to be crystal clear, this deep dive is purely an educational exploration of Trena's research, >> right? >> This is not financial advice and it is certainly not a recommendation to purchase assets. You must always do your own due diligence before investing. >> Always. >> Best of US investors operate strictly as an investment research and teaching company. I mean, they do not manage money. They don't provide copy trades and they do not manage cryptocurrency portfolios. >> The goal here is to learn how to analyze a complex narrative, right? Not just what to blindly buy. >> Exactly. >> Okay. So, with the guard rail securely in place, let's get into the actual mechanics of this pterodine situation because frankly, the setup on the chart is really messy right now. >> Oh, this roller coaster. >> It really is. I mean, the stock ran incredibly hard off an earnings print in late July, but then it gave almost all of that momentum right back. >> Yeah, it dropped about 15% in just a month. sliding right into correction territory. And just to add a little drama for you listening, the CEO actually sold 4,000 shares right in the middle of that drop. >> At around what, $425 a share? >> Yeah, right around there. So, the momentum is clearly broken. The obvious question you're probably asking is, why are we dedicating a deep dive to a stock that just kind of fell out of bed? Well, it's because the underlying catalyst, the robotics pivot itself, has fundamentally changed the math of the business. >> How so? >> So, for years, Pterodine basically framed its robotics division as this necessary diversification bet. You know, their core business is semiconductor testing equipment, >> which is notoriously cyclical, >> extremely cyclical. You have these massive boom years followed by just brutal bust years. So, they bought universal robots and a company called Mir to try and smooth out those cycles. Okay. So, the idea was when chip demand drops, they could just sell robots to car manufacturers to keep the revenue stable. >> That was the thesis. Yeah. But the reality for you listening was a 4-year slide. I mean, to put the actual numbers to it, robotics revenue went from $311 million in 2021, and they managed a tiny tick up to 326 million, but then it just fell right back down. >> Right. To like 304 million in 2023. >> Exactly. And then it ended up at 293 million in 2024. M >> that continuous slide is what triggered those two rounds of layoffs we mentioned. >> Cutting roughly a quarter of the workforce. That sounds like a textbook case of a legacy company trying to buy innovation and just well failing to integrate it. >> It really does. Right up until the market dynamic shifted completely. >> The AI pivot. >> Exactly. >> Yeah. >> Historically, the automotive sector was the primary buyer for these robotic arms and autonomous cars. >> Right. >> But suddenly electronics manufacturing and semiconductor assembly surged past automotive. It became the division's largest single end market. >> And the driver behind that shift is the explosion in AI data center construction right now. >> Yep. That specific electronics segment grew 50% quarter over quarter. >> So as a result, Q2 robotics revenue finally hit $und00 million, which is up 33% year-over-year. >> Wow. So it actually marked their fifth consecutive quarter of growth. >> It did. >> Okay, let me make sure I'm connecting these dots correctly for everyone listening. management refers to this as a wafer to AI data center pipeline. >> Right. >> So, Pterodine's legacy business is selling the machines that test semiconductor chips. >> Yes. >> But now, Pterodine's robotics division is literally building the robotic arms that assemble the server racks and data center hardware. Exactly. >> Hardware which will eventually house the very same chips that Pterodine's legacy equipment tests. >> You have the loop perfectly mapped out. They basically accidentally stumbled into this massive synergy. It's no longer just a diversification play meant to hedge against the cycle, right? >> It is now a second derivative play on the exact same AI capital expended super cycle. >> It is honestly the ultimate version of selling shovels in a gold rush. Except well, Pterodine isn't just selling the shovels to the miners. They are building the autonomous robotic factories that forged the shovels in the first place. >> That's a great way to put it. And the economics of that shovel factory have completely transformed because of those previous struggles we talked about. >> You mean the layoffs? >> Yeah. The restructuring they did in 2025 was super painful, but it consolidated their robotics brands. >> Okay. So, they took Universal Robots, which makes the articulated metal arms, and Mir R, which makes those autonomous mobile carts that drive around warehouse floors, >> right? and they smash them together into one unified sales and service team >> which strips out all the redundant management and overlapping software development. I assume >> exactly it fundamentally lowered the bar for success. That single consolidation move cut their breaking revenue requirement from $440 million all the way down to $365 million. >> They lowered their costs right as the AI data center demand spiked. I mean that is incredibly fortunate timing. >> It really is. If you look at the first half of 2026, the robotic segment generated $191 million. >> Okay, >> annualize that. And they are on pace to clear 400 million. That means 2026 will be the first year this segment actually crosses its new lower breaking in line and stops bleeding cash. >> Wait, how much cash had they lost before this? >> Historically, Pterodine has absorbed $231 million in life-to-day gap losses on this robotic stream. >> Oh, wow. 231 million. >> Yeah. But that massive cash bleed finally stops this year. >> I noticed in Tren's notes that a significant chunk of this turnaround is actually happening domestically, which you know ties into the whole reshoring narrative we're seeing across the tech sector right now. >> Yeah, the reshoring trend is a massive tailwind for them. Supply chain security is just paramount right now. US sales have already climbed to 32% of their total robotics revenue. >> That's a big chunk. >> It is. And to support that, they are opening a new manufacturing hub in Wixom, Michigan this year. M they'll start by building the universal robot cobots, >> you know, the collaborative robots domestically with plans to potentially build the mural autonomous mobile robots there down the line. >> Okay, so the why is clear. The AI data center buildout provides the demand and the restructuring provided the margins, right? >> But we really need to look at the how because the physical AI landscape is arguably the most cutthroat wellfunded space in technology right now. >> Oh, absolutely. You have companies pouring tens of billions into robotics. How is Pterodine positioning itself to actually survive that? >> Well, they are assembling a very specific deliberate physical AI stack. >> Mhm. >> They realize they can't just sell dumb metal arms anymore, >> right? >> So, first they completely rebuilt their operating system which they call Polycope X. >> Polycope X. Got it. >> It utilizes modern web technologies. Yeah. >> But its primary function is to act as a universal plug. It is designed to allow third-party AI brains to seamlessly connect to Pterodine's physical hardware. >> I want to dig into this plug concept because it feels like >> it really is and it leads directly into their next major product, the UR AI trainer, which they built in partnership with Scale AI. >> Okay. Scale AI is huge. >> Yeah. And this product is a masterclass in what the industry calls imitation learning. >> Okay. Let's break down imitation learning for the listener because the mechanics of this are pretty mindblowing compared to how we used to program robots. >> Yeah. Historically, if you wanted a robotic arm to pick up a fragile object, say an egg, without crushing it, a human programmer had to write thousands of lines of complex code, >> right? You'd have to calculate spatial coordinates, velocity, and like exact grip pressure thresholds. >> Exactly. It took weeks of tweaking. But with imitation learning, you bypass the code entirely. A factory worker simply grabs the robotic arm, physically moves it down to the egg, and guides the arm's pincers to gently pick it up. >> So, the human is just a physically puppeteering the machine through the task. >> Literally, yes. And while the human is doing that, the sensors inside Pterodine's arm are capturing what they call forceare data. >> Meaning the robot physically feels the resistance of the eggshell. >> Exactly. Yeah. >> It records the spatial path. It takes that physical sensory data and instantly writes the underlying model. You can train the robot in 10 minutes instead of 10 weeks. >> That is insane. >> And this software is already rolling out in physical products you can buy today like their new Miar 1200 pallet jack. >> That is incredible technology. But I do have to play devil's advocate here for a second. >> Go for it. >> You just mentioned they partnered with Scale AI. We have massive companies. I mean Open AI, Google, Tesla building foundational AI models with the smartest software engineers on Earth. >> Right? If software is basically eating the world, how does a hardware company like Pterodine avoid becoming completely commoditized? >> That tension between software and hardware is exactly why Pterodine strategy is so fascinating. They are deliberately choosing not to build a foundation model. >> Really? >> Yeah. They are actively opting out of the multi-billion dollar race to build the smartest AI brain. >> So they are just conceding the software war. >> They know they can't outspend or outenineer the tech giants on artificial intelligence. Ah >> so instead of trying to be the brain they are positioning themselves to be the body. >> Ah I see >> they are building the highly reliable safety rated force sensing physical platform. They want everyone else's AI models whether it scale AI Nvidia's Isaac stack or you know some startup we haven't even heard of yet to plug into their physical hardware. >> That makes a lot of strategic sense actually. If you look at large language models today text generation is already racing toward commoditization. >> Exactly. So if physical AI logic commoditizes in the same way, the real durable value, the actual moat isn't in owning the algorithm. Nope. >> It's in owning the trusted certified hardware that regulatory bodies actually allow on a factory floor next to human beings without the fear of it malfunctioning and hurting someone. >> Yes, the safety certification is a massive barrier to entry. Pterodine ERA's universal robots division already has about 100,000 arms deployed out in the real world. >> That's a huge footprint. it is. They have a certified integrator channel and an established app marketplace. I mean, you can invent the smartest, most capable AI model in the world in a lab in Silicon Valley, but if it doesn't have a reliable certified physical body to actually execute tasks in a Ford manufacturing plant, your software is basically useless. >> Pterodine owns the installed base. Exactly. >> But owning the hardware space isn't without its own existential threats or >> No, definitely not. The primary threat is form factor obsolescence. The industry is totally obsessed with humanoid robots right now. >> Like the Tesla Optimus stuff, >> right? If a bipedal humanoid robot suddenly becomes cheap and reliable enough to walk around a factory, it could completely eat the traditional stationary robotic arm use case. >> That makes sense. >> Furthermore, even if humanoids take a decade to mature, Pterodine is facing immediate margin pressure from incredibly cheap Chinese collaborative robots or, you know, cobots. >> Oh, the knockoffs. Yeah, and Pterodine is actively fighting this in court right now. They recently filed a copyright suit in Germany against Elite Robots, alleging they straight up copied Pterodine's Polycope 5 software. And Pterodine actually won an injunction there. >> Wow. The fact that they are having to litigate to protect their software from cheap hardware knockoffs shows just how vicious the physical AI space is getting. >> It really is a battleground. And that threat actually provides a perfect bridge to the other side of Trent Grink Meyer's analysis. Trent relies heavily on a concept he calls the tenth man rule. >> Yes, it's a vital mental model for investing. The premise is that if nine people in a room look at the exact same data and arrive at the exact same bullish conclusion, it is the duty of the tenth man to actively disagree and aggressively poke holes in the narrative. >> Basically, a forced mechanism to check your own biases. >> Exactly. Especially when dealing with something as hyped up as artificial intelligence. So, let's put on the tenth man hat for you listening because when you strip away the imitation learning and the data center buzzwords and you just look at the cold hard financial math, the Pterodine story gets a major reality check. >> The math is incredibly sobering. We have been raving about this $400 million robotic segment. Right. >> Right. >> In isolation, a $400 million run rate sounds fantastic, >> but you have to remember the context. Pterodine is a $55.8 8 billion company. >> Oh wow. >> Yeah. That futuristic robotics division we just spent 10 minutes talking about, it accounts for just 8% of their total revenue. >> Just 8%. >> Just 8%. And remarkably, because of the massive slowdown they experienced over the last few years, that 8% figure is actually down from late 2023 when robotics made up nearly 19% of the business. >> Let me contextualize what that means for you listening. If you buy this stock today because you are obsessed with the robotics and the physical AI thesis, you are actually just buying a massive highly cyclical semiconductor testing company that is trading at a staggering 48 times earnings and you are merely getting the robot story as a tiny 8% side hustle. >> At a 55 billion market cap, a $400 million segment simply does not move the valuation needle enough to justify a 48x multiple. The tail is just not big enough to wag the dog. >> And even if we focus just on that robotics tale, the growth narrative isn't as clean as it looks, is it? You mentioned they hit profitability in 2026, >> right? But the 10th man perspective demands we look at the lost time. Yes, they are projected to cross 400 million in 2026, but 2026 revenue is roughly just going to match the peak they hit all the way back in 2022. >> So they basically lost four years. It took them four brutal years and laying off 24% of their staff just to get back to flat. That is a lost half decade of growth in an industry that moves at lightning speed. >> That completely punctures the hyperrowth illusion. >> And the risk compounds when you look at how concentrated that future growth is. Pterodine's management openly expects one single large e-commerce customer to triple its contribution to the robotic segment in 2026. one customer reading the tea leaves of the logistics industry, that customer is almost certainly Amazon, right? >> Almost certainly. Yes. So, you don't just have a broad AI growth story. You have a narrative heavily concentrated in a single corporate relationship. >> Wow. >> If Amazon decides to slow capital expenditures or pivots to a different robotics vendor, Pterodine's 2026 projections fall apart instantly. >> That is a massive single point of failure for the 8% of the business we are so excited about. What about the other 92% the core semiconductor testing business? >> Well, it is a fundamentally strong business but like we said it is deeply cyclical and the cycle is the real danger at the specific moment. >> Right. >> Semiconductor testing goes through massive boom and bust phases based on global chip demand. Right now their Q3 guidance is already implying a sequential decline. We are seeing gross margins dip falling from 60.9% down to 59.8%. Meaning it's getting more expensive for them to produce their core testing equipment or they are losing pricing power. >> Exactly. And if the broader AI capital expenditure super cycle takes a breather, >> you know, if the massive tech companies decide they need to digest all the chips they bought over the last 2 years before ordering more Pterodine's core testing business will shrink. >> And if earnings drop, that 48x multiple is going to compress incredibly fast. the stock will get punished long before the tiny robotic segment can grow enough to offset those losses. >> So, we have a brilliant forward-looking AI hardware narrative colliding violently with a dangerous valuation and severe cyclical headwinds. >> It's a tough spot. >> How do you actually weigh those conflicting realities against each other without letting emotion dictate the outcome? I mean, this is where Trent Grinkmire's methodology becomes incredibly useful. Let's run Pterodine through his B US scorecard. Yeah, the BOS scorecard is trends proprietary framework. It takes technicals, fundamentals demand sentiment and macroeconomic factors, strips out the narrative bias and synthesizes it all into a single actionable score. >> Okay, what's the verdict? >> Starting with the raw composite score, Pterodine comes in at a 66.2. In trend system, a 66.2 actually places it at the very bottom edge of a buy band. >> I am genuinely surprised. A buy rating for a company trading at 48 times earnings facing a cyclical downturn. How does the math justify that? >> The fundamental score is carrying almost the entire weight of that rating. Pterodine scored a 78 out of 100 purely on fundamentals. Their balance sheet is an absolute fortress. >> Really? >> Yeah. They're sitting on $249 million in net cash. They have virtually zero debt. Their debt to equity ratio is 03. >> That's practically unheard of. and their interest coverage ratio is an absurd 106 times. Meaning their operating profit could cover their interest payments 106 times over. >> Okay, so the underlying engine of the business is pristine even if the sticker price of the stock is somewhat inflated. >> Their operational efficiency is off the charts. Trent heavily weighs a metric called the rule of 40. >> Oh, I've heard of that. It's a calculation where you take a company's revenue growth rate and add its profit margin. Right. >> Exactly. It's a simple but ruthless calculation. For a traditional manufacturing company, the benchmark for a healthy bedellers is usually a score of 18. Pterodine scored an 84.6. >> Wait, 84.6? That is almost suspiciously high for a hardware company. >> They clear the industry benchmark by nearly five times because their operating margins are sitting above 30%. >> With an underlying engine running that hot, why is the raw score barely clinging to a buyer rating? Because Trent applies several critical overlays to catch discrepancies that the raw numbers miss. The most important one here is the RPT overlay. >> RPT. >> It stands for receivables payment timing. He analyzes a company's day sales outstanding or DSO. This tracks how long it takes a company to actually collect cash after making a sale. >> Okay. >> Over the last five quarters, Pterodine's DSO crept up steadily. It went from 60 days to 63 to 71 to 79 before settling slightly at 76 days. Meaning it's taken them significantly longer to actually get paid by their clients. >> Yeah. >> Yeah. And when you look at the year-over-year data, it reveals a glaring divergence. Their accounts receivable, the money owed to them by clients grew by 156%. But their actual revenue only grew by 104%. >> That is a massive 52point divergence. Hold on, let's unpack the real world mechanics of that divergence for the listener. Why is the money owed to them growing so much faster than the money they are actually making? >> Good question. >> Are they just aggressively booking sales on paper to look good while their clients refuse to actually hand over the cash? >> That is the immediate red flag in any fundamental analysis in the hardware cycle. As macroeconomic conditions tighten, massive clients start throwing their weight around. >> Right? A major tech firm will say to Pterodine, "We will buy your $10 million testing machine, but we demand net 90 or net 120day payment terms." >> Ah, >> Pterodine gets to book that $10 million as revenue today, which makes the income statement look fantastic. But in reality, Pterodine is acting as a free bank for their clients, floating that $10 million for 4 months while they wait for the cash to actually hit their accounts. >> That completely skews the reality of their growth. But Tren's note suggests there is some nuance to this specific situation. Right. There is. Trent dug deeper into the sequential quarter overquarter data to see if the bleeding was getting worse. In Q2, their accounts receivable actually flattened out. It only moved from 117.5 million to 119.7 million even as revenue rose. >> Okay, that's reassuring. >> Furthermore, their Q2 operating cash flow was 469 million, which easily exceeded their net income of $347.5 million. The cash is indeed coming in the door right now. The massive drag on their income quality score is a hangover from older quarters, not a current crisis. >> So, the bleeding has stopped, but the damage to the balance sheet efficiency is already done. Between those creeping receivables from past quarters acting as a drag and the fact that you are paying a 48x price to earnings multiple as a cyclical downturn looms, Trent system has to penalize the final score. >> It does. Trend applies a neg3 modifier to the raw score to account for that valuation and the RPT divergence. That penalty drops Pterodine's adjusted composite score down to a 63.2. >> And that slight shift changes the entire verdict. >> It drops Pterodine out of the buy band entirely, moving it down to a whole D, sitting right at the absolute top of that band. >> Bringing this all together, the conclusion is really a masterclass and separating a great narrative from a good investment. >> Absolutely. The story we started with this incredible vision of a struggling robotics division transforming into the foundational physical infrastructure of the AI boom. That story is absolutely real. >> It is happening. >> Pterodine's strategy of abandoning the software wars to become the certified physical body for third party AI brains is brilliant. But you cannot ignore the math. >> No, you can't. You are being asked to pay a massive premium for a highly cyclical semiconductor testing company, hoping that an 8% robotic segment will eventually justify the price tag. As Trent perfectly summarizes in his analysis, the story is right, the entry isn't >> exactly. And for anyone tracking the stock, Trent suggests waiting out the current volatility. Watch the $300 to $315 zone to see where the stock's actual base forms rather than trying to catch a falling knife in the middle of a correction. And beyond just the stock price, what are the key fundamental metrics the listeners should be watching over the next few quarters? >> First, watch for the moment. Management officially discloses the robotics operating margin. Right now, it's basically buried. The moment they break out segment profit cleanly, the market will either rerate the story higher or the lack of true profitability will be exposed. >> Good point. >> Second, monitor that new Wixom, Michigan facility. see if they can push their US sales mix above 40% which significantly derisks their supply chain. Finally, you have to watch that e-commerce giant. If that presumed Amazon deal stalls out or shrinks, a massive chunk of their 2026 growth narrative simply evaporates. >> It is a brilliant hardware strategy operating with zero margin for error. And you know, the deeper implications of what Pterodine is building really leaves you with a wild thought to chew on. >> What's that? Well, we started this deep dive marveling at how Pterodine's robotic arms are building the AI data center hardware, which is then used to test more chips, right? But take that one step further. If Pterodine's physical robots are building the massive AI data centers, and those AI data centers are computing the imitation learning algorithms that make the next generation of robots smarter, how long until the physical infrastructure of the technology world is entirely self-replicating? >> Oh, wow. It becomes a completely closed loop. The physical tools are building the digital tools that make the physical tools smarter, requiring less and less human intervention at every step. >> It really changes how you view a simple robotic arm on a factory floor. To respect the incredible research provided by Trent Grinkmire and best of us investors today, we'll leave you with Trent's own philosophy for navigating these incredibly complex narrative-driven markets. Preserve, protect, grow. In that order, live loud. >> [music] [music] [music]

Comments 0

No comments yet. Be the first to share your thoughts!